EMMA FRANTZ: Open Payments
NPI 1588318182 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$795 in 33 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $795
Food & beverage: $795
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $251 |
| Ardelyx, Inc. | 3 | $74 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $72 |
| Regeneron Healthcare Solutions, Inc. | 3 | $69 |
| Madrigal Pharmaceuticals | 3 | $67 |
| Novo Nordisk Inc | 2 | $41 |
| Celltrion USA Inc. | 2 | $40 |
| Janssen Biotech, Inc. | 2 | $39 |
| Phathom Pharmaceuticals, Inc. | 2 | $30 |
| PFIZER INC. | 1 | $29 |
Products named: SKYRIZI, IBSRELA, DUPIXENT, REZDIFFRA, RINVOQ, ENTYVIO, Wegovy, VEGZELMA.
Industry payments across VA — which companies pay providers there.
